MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
FDMT Balance Sheet Sankey Diagram
Sankey diagram visualizing FDMT balance sheet for the period
Marketable securities
$290,962K
(34.66%↑ Y/Y)
Cash and cash
equivalents
$70,372K
(-8.80%↓ Y/Y)
Prepaid expenses and
other current assets
$17,012K
(69.07%↑ Y/Y)
Collaboration receivable
$4,611K
Total property and
equipment
$35,823K
(-1.33%↓ Y/Y)
Total current assets
$382,957K
(26.27%↑ Y/Y)
Marketable securities,
long-term
$69,295K
(-44.03%↓ Y/Y)
Operating lease
right-of-use assets, net
$16,548K
(-15.78%↓ Y/Y)
Property and equipment,
net
$12,379K
(-29.28%↓ Y/Y)
Other non-current
assets
$11,436K
(21.79%↑ Y/Y)
Less accumulated
depreciation and...
$23,444K
(24.69%↑ Y/Y)
Total assets
$492,615K
(4.01%↑ Y/Y)
Total liabilities and
stockholders equity
$492,615K
(4.01%↑ Y/Y)
Total stockholders
equity
$407,659K
(-3.14%↓ Y/Y)
Total liabilities
$84,956K
(61.06%↑ Y/Y)
Accumulated deficit
-$858,000K
(-26.39%↓ Y/Y)
Accumulated other
comprehensive gain (loss)
-$446K
(-232.34%↓ Y/Y)
Additional
paid-in-capital
$1,266,099K
(15.17%↑ Y/Y)
Total current
liabilities
$47,673K
(37.48%↑ Y/Y)
Long-term debt, net
$19,587K
Operating lease
liabilities, long-term...
$14,256K
(-17.86%↓ Y/Y)
Deferred revenue, net of
current portion
$2,955K
(1249.32%↑ Y/Y)
Derivative liability
$384K
(14.97%↑ Y/Y)
Other liabilities
$101K
(-37.27%↓ Y/Y)
Common stock, 0.0001
par value,...
$6K
(20.00%↑ Y/Y)
Accrued and other
current liabilities
$25,431K
(32.52%↑ Y/Y)
Accounts payable
$12,522K
(43.93%↑ Y/Y)
Operating lease
liabilities, current portion
$5,374K
(-6.07%↓ Y/Y)
Deferred grant
reimbursements
$3,986K
Deferred revenue
$360K
(-66.23%↓ Y/Y)
Back
Back
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)
Balance Sheet
Quarterly Balance Sheet for the quarter ending in 2026-06-30
source: myfinsight.com